We must pay attention to the need for more studies; with the suppressed polymorphisms and their association with the clinical severity variables using a larger number of CF ́s patients with the same CFTR genotype for the mutation classes I, II and/or III; also patients with the same degree of change in the spirometry test to analyze the response to Bronchodilation. The gene discussed is CFTR; the disease is cystic fibrosis.